Sequent Scientific Share Price

ABOUT Sequent Scientific

• Industry Biotechnology & Drugs
• ISIN INE807F01027
• BSE Code 512529
• NSE Code SEQUENT

SeQuent Scientific Limited is an India-based integrated pharmaceutical company with a global footprint, operating in the domains of animal health (active pharmaceutical ingredients (APIs), and finished dosage formulations) and analytical services. It has eight manufacturing facilities, based in India, Turkey, Brazil, Spain and Germany. Its geographical segments include Europe, Asia, and the Rest of the world. It is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It specializes in analytical and bioanalytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It offers analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer-developed methods or in-house method development.

MANAGEMENT

• Rajaram Narayanan Chief Executive Officer, Managing Director, Executive Director
• Saurav Bhala Chief Financial Officer
• Yoshita Vora Company Secretary and Compliance Officer
• Prasad Lad Vice President - Human Resources and Admin
• Phillip Trott Vice President - Legal
• Vedprakash Ragate Executive Director
• Yawar Abbas Emerging Markets
• Jose Filho Latin America Operations
• Alexis Goux Global Formulations
• Ashish Kakabalia Business Development and Research & Development